PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportshematologic diseases
MeSH D006402 - hematologic diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006425:Hemic and lymphatic diseases
$
Success rate
D006402: 
Hematologic diseases
$
Success rate
D001778:Blood coagulation disorders
0 Companies
0 Drugs
Success rate
D001791:Blood platelet disorders
0 Companies
0 Drugs
Success rate
D001796:Blood protein disorders
$
Success rate
D001855:Bone marrow diseases
$
Success rate
D004899:Fetal erythroblastosis
0 Companies
0 Drugs
Success rate
D006453:Hemoglobinopathies
0 Companies
0 Drugs
Success rate
D006474:Hemorrhagic disorders
$
Success rate
D007960:Leukocyte disorders
0 Companies
0 Drugs
Success rate
D008708:Methemoglobinemia
D011086:Polycythemia
0 Companies
0 Drugs
Success rate
D011250:Hematologic pregnancy complications
0 Companies
0 Drugs
Success rate
D011289:Preleukemia
0 Companies
0 Drugs
Success rate
D013436:Sulfhemoglobinemia
0 Companies
0 Drugs
Success rate
D019337:Hematologic neoplasms
$
Success rate
D019851:Thrombophilia
0 Companies
0 Drugs
Success rate
D065227:Transfusion reaction
0 Companies
0 Drugs
Success rate
D000095542:Cytopenia
0 Companies
0 Drugs
Success rate
D000740:Anemia
D007938:Leukemia
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaMethylprednisolone Methylprednisolone  2006-10-27   
Novast LaboratoriesMethylprednisolone Methylprednisolone  2019-01-09   
SandozMethylprednisolone Methylprednisolone  1997-10-31   
OrganonMethylprednisolone Methylprednisolone  1982-06-25   
PfizerMethylprednisolone Depo-medrol  1982-01-01   
Methylprednisolone Medrol  1982-01-01 $339 M Y2023 
Zydus TherapeuticsMethylprednisolone Methylprednisolone  2018-04-23   
HospiraMethylprednisolone A-methapred  2005-12-20   
Amneal PharmaceuticalsMethylprednisolone Methylprednisolone  2021-09-21   
Par PharmaceuticalMethylprednisolone Methylprednisolone  1988-04-25   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
81%
29/36
Phase 2
16%
10/63
Phase 3
12%
2/17
Approved: 2Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Pfizer
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use